Stoke Therapeutics Inc. (STOK) Files $400M Mixed Shelf
Get Alerts STOK Hot Sheet
Join SI Premium – FREE
Stoke Therapeutics Inc. (NASDAQ: STOK) has filed $400,000,000 mixed shelf of: Common Stock, Preferred Stock, Debt Securities, Warrants, Subscription Rights and Units
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apollo Global Management (APO) to Buy US Silica (SLCA) for $15.50/sh Cash
- XP (XP) Appoints Victor Mansur as Chief Financial Officer Effective August 1, 2024
- Atlassian (TEAM) comes ahead of Street estimates in Q1 but shares tumble
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!